Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 17  •  02:31PM ET
96.60
Dollar change
-2.89
Percentage change
-2.90
%
Today, 12:52 PMMedtronic posts a fiscal Q4 beat (non-GAAP EPS $1.36; revenue $9.0B, +9% YoY; 6% organic growth) and reaffirms its FY26–FY27 outlook, while warning new tariff settlements will create headwinds of about $185M in FY26 and ~$300M in FY27 that will pressure margins.
IndexS&P 500 P/E26.10 EPS (ttm)3.70 Insider Own0.08% Shs Outstand1.28B Perf Week-4.97%
Market Cap123.84B Forward P/E15.77 EPS next Y6.13 Insider Trans-3.17% Shs Float1.28B Perf Month-2.42%
Enterprise Value144.82B PEG2.57 EPS next Q1.69 Inst Own87.29% Short Float1.54% Perf Quarter0.48%
Income4.76B P/S3.56 EPS this Y2.90% Inst Trans0.41% Short Ratio2.54 Perf Half Y3.85%
Sales34.76B P/B2.55 EPS next Y8.44% ROA5.26% Short Interest19.72M Perf YTD0.56%
Book/sh37.95 P/C14.87 EPS next 5Y6.14% ROE9.81% 52W High106.33 -9.15% Perf Year4.08%
Cash/sh6.50 P/FCF23.79 EPS past 3/5Y-1.03% 0.39% ROIC6.24% 52W Low79.55 21.43% Perf 3Y13.91%
Dividend Est.2.85 (2.95%) EV/EBITDA15.27 Sales past 3/5Y1.91% 3.01% Gross Margin59.95% Volatility2.38% 2.18% Perf 5Y-18.25%
Dividend TTM2.83 (2.93%) EV/Sales4.17 EPS Y/Y TTM13.15% Oper. Margin18.61% ATR (14)2.31 Perf 10Y27.78%
Dividend Ex-DateDec 26, 2025 Quick Ratio1.80 Sales Y/Y TTM5.34% Profit Margin13.71% RSI (14)34.64 Recom1.91
Dividend Gr. 3/5Y3.57% 5.33% Current Ratio2.42 EPS Q/Q8.10% SMA20-4.45% Beta0.72 Target Price112.42
Payout77.47% Debt/Eq0.60 Sales Q/Q6.64% SMA50-2.89% Rel Volume1.63 Prev Close99.49
Employees95000 LT Debt/Eq0.57 EarningsFeb 17 BMO SMA2003.37% Avg Volume7.77M Price96.60
IPONov 21, 1977 Option/ShortYes / Yes EPS/Sales Surpr.1.82% 1.25% Trades Volume9,939,466 Change-2.90%
Date Action Analyst Rating Change Price Target Change
Feb-13-26Resumed Barclays Overweight $116
Feb-09-26Upgrade Needham Hold → Buy $121
Feb-03-26Resumed Citigroup Buy $117
Jan-30-26Resumed Wells Fargo Overweight $114
Jan-06-26Upgrade William Blair Mkt Perform → Outperform
Nov-19-25Upgrade Goldman Sell → Neutral $111
Jun-30-25Upgrade Wolfe Research Underperform → Peer Perform
Jun-16-25Initiated Leerink Partners Outperform $110
Mar-04-25Upgrade Citigroup Neutral → Buy $92 → $107
Oct-10-24Upgrade RBC Capital Mkts Sector Perform → Outperform $98 → $105
Today 02:09PM
02:00PM
01:46PM
12:33PM
12:32PM
12:17PM Loading…
12:17PM
11:11AM
10:48AM
10:35AM
10:20AM
09:42AM
09:41AM
09:40AM
09:34AM
09:34AM
09:30AM Loading…
09:30AM
09:21AM
07:55AM
07:40AM
07:27AM
07:05AM
06:53AM
06:45AM
06:44AM
03:45AM
03:45AM
Feb-16-26 09:55AM
09:42AM
07:00AM
Feb-15-26 01:00PM
07:57AM Loading…
07:57AM
Feb-13-26 07:00PM
03:30PM
11:04AM
09:49AM
08:38AM
08:01AM
08:00AM
Feb-11-26 01:56PM
11:14AM
09:15AM
Feb-09-26 05:45PM
10:54AM
09:36AM
08:02AM
07:43AM
Feb-06-26 01:14PM
Feb-05-26 02:21PM
Feb-04-26 06:42AM
Feb-03-26 05:55PM
12:21PM
11:18AM
08:17AM
08:00AM
06:11AM
Feb-02-26 11:08AM
09:17AM
Jan-30-26 05:50PM
05:10PM
02:31PM
09:54AM
07:59AM
Jan-27-26 02:13PM
05:23AM
05:00AM
Jan-26-26 05:54PM
05:39AM
Jan-24-26 09:01AM
Jan-23-26 01:57PM
11:07AM
07:59AM
07:02AM
Jan-22-26 05:50PM
10:03AM
05:41AM
Jan-21-26 07:07PM
12:30PM
07:59AM
05:50AM
Jan-18-26 04:35PM
Jan-16-26 12:45PM
07:18AM
Jan-15-26 09:36AM
08:42AM
05:00AM
Jan-14-26 10:13AM
Jan-13-26 02:07PM
01:40PM
01:02PM
12:19PM
07:48AM
Jan-12-26 09:00AM
07:45AM
Jan-09-26 01:24PM
09:50AM
09:16AM
08:16AM
Jan-08-26 11:40AM
Jan-07-26 09:05AM
08:41AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Gregory LEVP Global Ops & Supply ChainNov 19 '25Sale101.9530,0003,058,45146,016Nov 21 04:13 PM
Smith Gregory LOfficerNov 19 '25Proposed Sale101.9530,0003,058,452Nov 19 11:05 AM
KIIL HARRY SKIPEVP & President CardiovascularSep 03 '25Sale91.588,605788,04835,615Sep 05 04:18 PM
KIIL HARRY SKIPOfficerSep 03 '25Proposed Sale91.588,605788,049Sep 03 03:23 PM
Jellison William RDirectorAug 22 '25Buy92.732,500231,8252,500Aug 25 05:18 PM
Jellison William RDirectorAug 25 '25Buy92.372,500230,9255,000Aug 25 05:18 PM
Walter Matthew R.SVP, Chief HR OfficerAug 01 '25Option Exercise23.913,14275,11432,804Aug 04 04:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 01 '25Option Exercise0.0015,249066,531Aug 04 04:20 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 01 '25Option Exercise0.0011,328083,071Aug 04 04:19 PM
Martha GeoffreyChairman and CEOAug 01 '25Option Exercise32.2198,3243,166,800284,923Aug 04 04:18 PM
Marinaro MichaelEVP, Pres MedSurg and AmericasAug 01 '25Option Exercise25.249,661243,82857,628Aug 04 04:17 PM
KIIL HARRY SKIPEVP & President CardiovascularAug 01 '25Option Exercise0.0010,457051,775Aug 04 04:16 PM
Blomquist Denise L.Chief Accounting OfficerAug 01 '25Option Exercise32.2251816,69212,671Aug 04 04:15 PM
Salmon SeanOfficerJun 06 '25Proposed Sale86.8118,3781,595,469Jun 06 02:43 PM